| Frequency
of Abs against L514S, L552S and NY-ESO-1 in the sera of stage
I-IV NSCLC patients from the US and Japan.
| Study
Group |
Country |
Specimens |
Frequency
of Abs against CT Antigen |
| L514S |
L552S |
NY-ESO-1 |
| NSCLC
patients |
US |
sera |
13/90 (14%) |
11/90 (12%) |
3/90 (3.3%) |
| Japan |
sera
(low titer, >x102) |
7/60 |
10/60 |
1/60 |
| sera
(high titer, >x104) |
0/60 |
4/60 |
4/60 |
| total |
7/60 (12%) |
14/60 (23%) |
5/60 (8.3%) |
| US + Japan |
total |
20/150 (13%) |
25/150 (17%) |
8/150 (5.3%) |
| Normal volunteers |
US |
sera |
0/48 (0%) |
0/48 (0%) |
0/48 (0%) |
|
